Transparency Market Research in its new report titled, “Amenorrhea Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2026,” provides key insights on the amenorrhea market. The TMR report anticipates that the rise in number of cases of amenorrhea and increasing female geriatric population will drive the amenorrhea market during the forecast period i.e, 2018-2026. In certain regions of North America, secondary amenorrhea is more common in women than primary amenorrhea. Moreover, the market is driven by advancements in technology and rise in interest in research and development. The global amenorrhea market is also fuelled by rise in interest in personal care items. The global amenorrhea market is projected to expand at a rapid pace during the forecast period, says the report. However, the report also discusses market restraints such as poor awareness and absence of open-mindedness among females in developing regions that is restraining the global amenorrhea market. Nonetheless, untapped areas of the market and advancements in health care are expected to offer lucrative opportunities during the forecasted period, the report says.
The TMR report has segmented the global amenorrhea market in terms of type of amenorrhea, drug, and region. In terms of type of amenorrhea, the global amenorrhea market is classified into primary amenorrhea and secondary amenorrhea. The secondary amenorrhea segment dominates the global market, and the trend is expected to continue during the forecasted period. On the basis drug, the global amenorrhea market is divided into clomiphene citrate therapy, estrogen replacement therapy, hormonal medication, and others. The hormonal medication segment holds a prominent market share and is expected to continue to dominate the market during the forecast period.
From a regional perspective, the global amenorrhea market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among these, North America accounts for a significant market share owing to high number of research and development activities, significant geriatric population, and availability of advanced health care facilities. Europe is a key region of the amenorrhea drugs market due to the presence of companies engaged in scientific research and rise in demand for pharmaceutical industry in this region. However, stringent regulatory policies pertaining to new drug development can restrain the expansion of the amenorrhea market in Europe during the forecast period. Asia Pacific and Latin America are emerging regions of the market. The market in the regions is expected to expand at a rapid pace during the forecast period. This is due to changes in diet and lifestyle and increasing government investment to develop accessibility to health care infrastructure. The amenorrhea drugs market in countries such as China, India, and Brazil is projected to expand at a high growth rate during the forecast period due to increase in awareness among the population about amenorrhea and its treatment.
Some of the major players operating in the global amenorrhea market are profiled in this report and these include VH Nutrition LLC, Greenstone LLC, Teva Pharmaceuticals USA, Inc., Pfizer Inc., Dr. Reddy’s Laboratories, Inc., and Akorn, Inc.
About Us
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]